MannKind (MNKD) Stock Heads Up On NDA Acceptance

MannKind MNKD Stock News

MannKind Corporation (NASDAQ: MNKD) is headed up in the premarket hours this morning, and for good reason. The company announced that the FDA has accepted a New Drug Application for priority review. Here’s what’s happening: Stop wasting your time! Start finding winning trades in minutes with Trade Ideas! MNKD Heads Up On Priority Review Acceptance … Read more